Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-01-15 @ 3:51 PM
Study NCT ID:
NCT06475820
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-23
First Post:
2024-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-17
First Submit QC Date:
None
Study First Post Date:
2024-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-22
Last Update Post Date:
2024-08-23
Last Update Post Date Type:
ACTUAL